Free Trial

SAB Biotherapeutics (SABSW) Short Interest Ratio & Short Volume

$0.08 -0.05 (-40.30%)
As of 01/14/2025 03:49 PM Eastern

SAB Biotherapeutics Short Interest Data

SAB Biotherapeutics (SABSW) has a short interest of 2,800 shares. This marks a 64.71% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 16,116 shares to cover all short positions.

Current Short Interest
2,800 shares
Previous Short Interest
1,700 shares
Change Vs. Previous Month
+64.71%
Dollar Volume Sold Short
$210.84
Short Interest Ratio
0.2 Days to Cover
Last Record Date
December 31, 2024
Today's Trading Volume
7,329 shares
Average Trading Volume
16,116 shares
Today's Volume Vs. Average
45%
Short Selling SAB Biotherapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for SAB Biotherapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SABSW Short Interest Over Time

SABSW Days to Cover Over Time

SABSW Percentage of Float Shorted Over Time

SAB Biotherapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
12/31/20242,800 shares $210.84 +64.7%N/A0.2 $0.08
12/15/20241,700 shares $86.70 -60.5%N/A0.1 $0.05
11/30/20244,300 shares $290.25 +72.0%N/A0.3 $0.07
11/15/20242,500 shares $208.25 +2,400.0%N/A0.2 $0.08
10/31/2024100 shares $5.26 -98.1%N/A0 $0.05
10/15/20245,200 shares $202.80 -56.7%N/A0.5 $0.04
9/30/202412,000 shares $432.00 +0.8%N/A1.4 $0.04
9/15/202411,900 shares $297.50 -5.6%N/A1.4 $0.03
8/31/202412,600 shares $598.50 +12,500.0%N/A1.4 $0.05
8/15/2024100 shares $3.73 No ChangeN/A0 $0.04
7/31/2024100 shares $5.00 -90.0%N/A0 $0.05
7/15/20241,000 shares $38.30 No ChangeN/A0.1 $0.04
3/31/2024100 shares $3.90 -97.9%N/A0 $0.04
3/15/20244,700 shares $142.41 -16.1%N/A0.3 $0.03
2/29/20245,600 shares $179.20 +600.0%N/A0.3 $0.03
2/15/2024800 shares $13.52 +700.0%N/A0 $0.02
1/31/2024100 shares $2.10 No ChangeN/A0 $0.02
11/30/20231,300 shares $59.93 -71.7%N/A0.3 $0.05
11/15/20234,600 shares $285.66 -11.5%N/A1.6 $0.06
10/31/20235,200 shares $474.38 +271.4%N/A2.1 $0.09
10/15/20231,400 shares $98.00 +7.7%N/A0.4 $0.07
9/30/20231,300 shares $91.00 -23.5%N/A0.4 $0.07
9/15/20231,700 shares $144.93 -46.9%N/A0.3 $0.09
8/31/20233,200 shares $256.03 -15.8%N/A0.4 $0.08
8/15/20233,800 shares $417.62 +123.5%N/A0.5 $0.11
7/31/20231,700 shares $161.50 -50.0%N/A0.1 $0.10
7/15/20233,400 shares $340.00 -49.3%N/A0.2 $0.10
6/30/20236,700 shares $699.48 +21.8%N/A0.2 $0.10
6/15/20235,500 shares $770.00 -35.3%N/A0.2 $0.14
5/31/20238,500 shares $1,275.00 -50.0%N/A0.3 $0.15
5/15/202317,000 shares $2,720.00 No ChangeN/A0.7 $0.16
3/15/20238,100 shares $379.07 -64.9%N/A1.5 $0.05
2/28/202323,100 shares $1,157.33 -9.8%N/A3.6 $0.05
2/15/202325,600 shares $1,336.32 -17.7%N/A3.4 $0.05
1/31/202331,100 shares $2,058.82 +10.7%N/A3.3 $0.07
1/15/202328,100 shares $1,657.90 +1.4%N/A2.5 $0.06
12/30/202227,700 shares $1,301.90 -2.1%N/A2.2 $0.05
12/15/202228,300 shares $1,415.00 +4.4%N/A1.4 $0.05
11/30/202227,100 shares $1,617.87 -18.9%N/A1.2 $0.06
11/15/202233,400 shares $2,478.28 +10.2%N/A1.5 $0.07
10/31/202230,300 shares $1,742.25 +20.2%N/A1.1 $0.06
10/15/202225,200 shares $1,638.00 -0.8%N/A1 $0.07
9/30/202225,400 shares $1,590.04 -2.7%N/A1 $0.06
9/15/202226,100 shares $1,827.00 -1.9%N/A1.5 $0.07
8/31/202226,600 shares $2,128.00 -27.7%N/A1.6 $0.08
8/15/202236,800 shares $4,864.96 +25.2%N/A2.2 $0.13
7/31/202229,400 shares $4,077.78 -5.5%N/A1.9 $0.14
7/15/202231,100 shares $5,287.00 -0.6%N/A2.2 $0.17
6/30/202231,300 shares $5,947.00 +1.6%N/A2.2 $0.19
6/15/202230,800 shares $5,544.00 -4.6%N/A1.9 $0.18
5/31/202232,300 shares $5,290.74 -22.4%N/A2.1 $0.16
5/15/202241,600 shares $9,977.72 -7.1%N/A1.4 $0.24
4/30/202244,800 shares $12,606.72 +11.7%N/A1.5 $0.28
4/15/202240,100 shares $11,228.00 +2.6%N/A1 $0.28
3/31/202239,100 shares $0.00 +2.4%N/A0.8 $0.00

SABSW Short Interest - Frequently Asked Questions

What is SAB Biotherapeutics' current short interest?

Short interest is the volume of SAB Biotherapeutics shares that have been sold short but have not yet been closed out or covered. As of December 31st, investors have sold 2,800 shares of SABSW short. Learn More on SAB Biotherapeutics' current short interest.

Is SAB Biotherapeutics' short interest increasing or decreasing?

SAB Biotherapeutics saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 2,800 shares, an increase of 64.7% from the previous total of 1,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks.

What does it mean to sell short SAB Biotherapeutics stock?

Short selling SABSW is an investing strategy that aims to generate trading profit from SAB Biotherapeutics as its price is falling. SABSW shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against SAB Biotherapeutics?

A short squeeze for SAB Biotherapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SABSW, which in turn drives the price of the stock up even further.

How often is SAB Biotherapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SABSW, twice per month. The most recent reporting period available is December, 31 2024.




This page (NASDAQ:SABSW) was last updated on 1/15/2025 by MarketBeat.com Staff
From Our Partners